Psychologic Disorders and Statin Use: A Propensity Score‐Matched Analysis

To evaluate the association between statin therapy and the risk of psychologic disorders including schizophrenia, psychosis, major depression, and bipolar disorder in a military population.

[1]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[2]  R. S. Rosenson,et al.  Lovastatin-associated sleep and mood disturbances. , 1993, The American journal of medicine.

[3]  L. Launer,et al.  Nonresponse pattern and bias in a community-based cross-sectional study of cognitive functioning among the elderly. , 1994, American journal of epidemiology.

[4]  C. Steiner,et al.  Comorbidity measures for use with administrative data. , 1998, Medical care.

[5]  B. Golomb.  Cholesterol and Violence: Is There A Connection? , 1998, Annals of Internal Medicine.

[6]  J. Simes,et al.  Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators. , 2000, Archives of internal medicine.

[7]  J. Simes,et al.  Long-term Assessment of Psychological Well-being in a Randomized Placebo-Controlled Trial of Cholesterol Reduction With Pravastatin , 2000 .

[8]  Sascha O. Becker,et al.  Estimation of Average Treatment Effects Based on Propensity Scores , 2002 .

[9]  B. Sianesi,et al.  PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing , 2003 .

[10]  A. Jula,et al.  Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial , 2003, Psychoneuroendocrinology.

[11]  P. Doraiswamy,et al.  Statin‐Associated Memory Loss: Analysis of 60 Case Reports and Review of the Literature , 2003, Pharmacotherapy.

[12]  O. Wolkowitz,et al.  Behavioral implications of lowering cholesterol levels: a double-blind pilot study. , 2003, Psychosomatics.

[13]  K. Chan,et al.  Long-term statin use and psychological well-being. , 2003, Journal of the American College of Cardiology.

[14]  B. Golomb,et al.  Severe irritability associated with statin cholesterol-lowering drugs. , 2004, QJM : monthly journal of the Association of Physicians.

[15]  I. Civil,et al.  Co-morbidities in trauma patients: common and significant. , 2004, The New Zealand medical journal.

[16]  Donald R. Miller,et al.  Comorbidity Assessments Based on Patient Report: Results From the Veterans Health Study , 2004, The Journal of ambulatory care management.

[17]  Luis G. Vargas,et al.  A Data Mining Approach to Characterizing Medical Code Usage Patterns , 2002, Journal of Medical Systems.

[18]  R. Češka,et al.  Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission , 2005, Psychiatry Research.

[19]  P. S. Gregoor.  Atorvastatin may cause nightmares , 2006, BMJ : British Medical Journal.

[20]  I. Katz,et al.  Simvastatin Causes Changes in Affective Processes in Elderly Volunteers , 2006, Journal of the American Geriatrics Society.

[21]  R. Savage,et al.  Psychiatric Adverse Reactions with Statins, Fibrates and Ezetimibe , 2007, Drug safety.

[22]  Matthew F. Muldoon,et al.  Serum omega-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers. , 2007, Psychiatry research.

[23]  T. Ng,et al.  Association between depressive symptoms and use of HMG-CoA reductase inhibitors (statins), corticosteroids and histamine H(2) receptor antagonists in community-dwelling older persons: cross-sectional analysis of a population-based cohort. , 2008, Drugs & aging.

[24]  Charles Moniz.  Outpatient Workload (RVU) Predictors: Age, Gender & Beneficiary Category , 2008 .

[25]  C. Gantt,et al.  Analysis of weight and associated health consequences of the active duty staff at a major Naval medical center. , 2008, Military medicine.

[26]  Candice L. Garwood,et al.  Behavioral changes with paranoia in an elderly woman taking atorvastatin. , 2008, The American journal of geriatric pharmacotherapy.

[27]  William Encinosa,et al.  [Table, Diagnoses, ICD-9-CM, and Clinical Classifications Software (CCS), and Diagnosis-Related Groups (DRGs)]. , 2008 .

[28]  T. Ng,et al.  Association between Depressive Symptoms and Use of HMG-CoA Reductase Inhibitors (Statins), Corticosteroids and Histamine H2 Receptor Antagonists in Community-Dwelling Older Persons , 2008, Drugs & aging.

[29]  Kathy Helmick,et al.  Acute clinical care and care coordination for traumatic brain injury within Department of Defense. , 2009, Journal of rehabilitation research and development.

[30]  B. Golomb,et al.  Statin‐Associated Adverse Cognitive Effects: Survey Results from 171 Patients , 2009, Pharmacotherapy.

[31]  M. Maes,et al.  Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. , 2009, Neuro endocrinology letters.

[32]  L. Mascitelli,et al.  The double-edged sword of statin immunomodulation. , 2009, International journal of cardiology.

[33]  E. Kua,et al.  Statin use and depressive symptoms in a prospective study of community‐living older persons , 2010, Pharmacoepidemiology and drug safety.

[34]  N. Chauhan,et al.  Synergistic benefits of erythropoietin and simvastatin after traumatic brain injury , 2010, Brain Research.

[35]  L. Brinton,et al.  Oral contraceptive use among women in the military and the general U.S. population. , 2010, Journal of women's health.

[36]  N. Elmalı,et al.  The influence of atorvastatin on tendon healing: an experimental study on rabbits. , 2010, Orthopedics.

[37]  S. Shrivastava,et al.  Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin(1A) receptors. , 2010, Biochemistry.

[38]  B. Palmier,et al.  Simvastatin in traumatic brain injury: Effect on brain edema mechanisms , 2011, Critical care medicine.

[39]  John D. Childs,et al.  Brief psychosocial education, not core stabilization, reduced incidence of low back pain: results from the Prevention of Low Back Pain in the Military (POLM) cluster randomized trial , 2011, BMC medicine.

[40]  E. Spatz,et al.  Statin myopathy: A common dilemma not reflected in clinical trials , 2011, Cleveland Clinic Journal of Medicine.

[41]  Post-polio syndrome, spinal cord injury and statin myopathy: double trouble or incorrect diagnosis? Two case reports. , 2011, Journal of rehabilitation medicine.

[42]  C. Otte,et al.  Statin use and risk of depression in patients with coronary heart disease: longitudinal data from the Heart and Soul Study. , 2012, The Journal of clinical psychiatry.

[43]  M. Olfson,et al.  Race and the clinical diagnosis of depression in new primary care patients. , 2012, General hospital psychiatry.